GB202016889D0
|
|
Secure communication
|
GB202015681D0
|
|
Methods and apparatus for coherent signal transmission
|
GB202015564D0
|
|
Mutated plant
|
GB202011442D0
|
|
Isolation of cannabinoids using mesoporous materials
|
GB202005726D0
|
|
Organometallic gels
|
GB202001106D0
|
|
Light modulator with variable transparency
|
GB202000378D0
|
|
Lignin depolymerisation
|
GB201918010D0
|
|
Acoustic measurements
|
GB201907512D0
|
|
Compounds containing a quaternary centre
|
GB201907130D0
|
|
Dehydrogenase and chytochrome P450 polypeptides
|
GB201906790D0
|
|
Sensor system and fluid flow pathway system therefor
|
GB201903515D0
|
|
Methods and apparatus for coherent signal amplification and detection
|
GB201901060D0
|
|
Service cell selection
|
WO2019145693A1
|
|
Inhibitory agent
|
GB201820267D0
|
|
Proof-of-work for blockchain applications
|
GB201818171D0
|
|
A series of catalysts for the hyperpolarisation of substrates including pyruvaten through polarisation transfer from protons derived from parahydrogen
|
GB201816820D0
|
|
Diagnostic method
|
GB201813721D0
|
|
Treatment of urinary tract disorders
|
GB201812657D0
|
|
Inhibitory agent
|
EP3658945A2
|
|
Hyperpolarising substrates through relayed transfer via systems containing exchangeable protons
|